Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 5180165, 13 pages
https://doi.org/10.1155/2018/5180165
Research Article

Herba Artemisiae Capillaris Extract Prevents the Development of Streptozotocin-Induced Diabetic Nephropathy of Rat

1Institute of Virology and AIDS, The First Hospital of Jilin University, Jilin University, Dongminzhu Street 519, Changchun 130000, China
2Department of Experimental Pharmacology and Toxicology, School of Pharmacy, Jilin University, Fujin Road 1266, Changchun 130021, China
3Acupuncture Department, The Affiliated Hospital to Changchun University of Chinese Medicine, 1478 Gongnong Road, Changchun 130021, China
4Department of Pharmacology, College of Basic Medical Science, Jilin University, Xinmin Street 126, Changchun 130021, China
5Department of Obstetrics Gynecology, The Second Hospital of Jilin University, Ziqiang Street 218, Changchun 130041, China

Correspondence should be addressed to Yinggang Zou; nc.ude.ulj@gyuoz and Jinghua Yu; moc.361@2002-0-hjy

Received 18 August 2017; Revised 1 December 2017; Accepted 26 December 2017; Published 14 February 2018

Academic Editor: Youn C. Kim

Copyright © 2018 Jianan Geng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. W. Park, “Diabetic kidney disease: from epidemiology to clinical perspectives,” Diabetes & Metabolism Journal, vol. 38, no. 4, pp. 252–260, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. W. Albers and R. Pop-Busui, “Diabetic neuropathy: mechanisms, emerging treatments, and subtypes,” Current Neurology and Neuroscience Reports, vol. 14, no. 8, article 473, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. I. H. de Boer, T. C. Rue, Y. N. Hall, P. J. Heagerty, N. S. Weiss, and J. Himmelfarb, “Temporal trends in the prevalence of diabetic kidney disease in the United States,” Journal of the American Medical Association, vol. 305, no. 24, pp. 2532–2539, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. M. Nentwich and M. W. Ulbig, “Diabetic retinopathy—ocular complications of diabetes mellitus,” World Journal of Diabetes, vol. 6, no. 3, pp. 489–499, 2015. View at Publisher · View at Google Scholar
  5. R. Tarquini, C. Lazzeri, L. Pala, C. M. Rotella, and G. F. Gensini, “The diabetic cardiomyopathy,” Acta Diabetologica, vol. 48, no. 3, pp. 173–181, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. S. O. Kolset, F. P. Reinholt, and T. Jenssen, “Diabetic nephropathy and extracellular matrix,” Journal of Histochemistry & Cytochemistry, vol. 60, no. 12, pp. 976–986, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. Dormandy, B. Charbonnel, D. J. A. Eckland et al., “Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): a randomised controlled trial,” The Lancet, vol. 366, no. 9493, pp. 1279–1289, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Bell, E. H. Fletcher, I. Brady et al., “End-stage renal disease and survival in people with diabetes: a national database linkage study,” QJM: Monthly Journal of the Association of Physicians, vol. 108, no. 2, pp. 127–134, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. E. A. Lee, J. Y. Seo, Z. Jiang et al., “Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney,” Kidney International, vol. 67, no. 5, pp. 1762–1771, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Mohanty, W. Hamouda, R. Garg, A. Aljada, H. Ghanim, and P. Dandona, “Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes,” The Journal of Clinical Endocrinology & Metabolism, vol. 85, no. 8, pp. 2970–2973, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. R. M. Mason and N. A. Wahab, “Extracellular matrix metabolism in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 14, no. 5, pp. 1358–1373, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Pautz, R. Franzen, S. Dorsch et al., “Cross-talk between nitric oxide and superoxide determines ceramide formation and apoptosis in glomerular cells,” Kidney International, vol. 61, no. 3, pp. 790–796, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. W. L. Chandler, “A kinetic model of the circulatory regulation of tissue plasminogen activator,” Thromb Haemost, vol. 66, no. 3, pp. 321–328, 1991. View at Google Scholar
  14. J. Keeling and G. A. Herrera, “Human matrix metalloproteinases: characteristics and pathologic role in altering mesangial homeostasis,” Microscopy Research and Technique, vol. 71, no. 5, pp. 371–379, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. K. Ghosh and D. E. Vaughan, “PAI-1 in tissue fibrosis,” Journal of Cellular Physiology, vol. 227, no. 2, pp. 493–507, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. B. Nicholas, E. Aguiniga, Y. Ren et al., “Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy,” Kidney International, vol. 67, no. 4, pp. 1297–1307, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Murphy, “Tissue inhibitors of metalloproteinases,” Genome Biology, vol. 12, no. 11, p. 233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. C. M. Overall, “Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites,” Molecular Biotechnology, vol. 22, no. 1, pp. 51–86, 2002. View at Google Scholar · View at Scopus
  19. B. Fleckenstein, S.-W. Qiao, M. R. Larsen, G. Jung, P. Roepstorff, and L. M. Sollid, “Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides,” The Journal of Biological Chemistry, vol. 279, no. 17, pp. 17607–17616, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Lorand and R. M. Graham, “Transglutaminases: crosslinking enzymes with pleiotropic functions,” Nature Reviews Molecular Cell Biology, vol. 4, no. 2, pp. 140–156, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. J.-M. Han, H.-G. Kim, M.-K. Choi et al., “Artemisia capillaris extract protects against bile duct ligation-induced liver fibrosis in rats,” Experimental and Toxicologic Pathology, vol. 65, no. 6, pp. 837–844, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. C.-S. He, H.-Y. Yue, J. Xu et al., “Protective effects of capillary artemisia polysaccharide on oxidative injury to the liver in rats with obstructive jaundice,” Experimental and Therapeutic Medicine, vol. 4, no. 4, pp. 645–648, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. H. S. Lee, H. H. Kim, and S. K. Ku, “Hepatoprotective effects of Artemisiae capillaris herba and picrorrhiza rhizoma combinations on carbon tetrachloride-induced subacute liver damage in rats,” Nutrition Research, vol. 28, no. 4, pp. 270–277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Kowalski, A. Krikorian, and E. V. Lerma, “Diabetic nephropathy for the primary care provider: new understandings on early detection and treatment,” Ochsner Journal, vol. 14, 369, no. 3, p. 379, 2014. View at Google Scholar
  25. J. Pan, G. Liu, H. Liu, Z. Qiu, and L. Chen, “Effects of artemisia capillaris on blood glucose and lipid in mice,” Zhong Yao Cai, vol. 21, no. 8, pp. 408–411, 1998. View at Google Scholar · View at Scopus
  26. Y.-H. Chang, D.-M. Chang, K.-C. Lin, C.-H. Hsieh, and Y.-J. Lee, “High-density lipoprotein cholesterol and the risk of nephropathy in type 2 diabetic patients,” Nutrition, Metabolism & Cardiovascular Diseases, vol. 23, no. 8, pp. 751–757, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. R. A. Kowluru, M. Mishra, A. Kowluru, and B. Kumar, “Hyperlipidemia and the development of diabetic retinopathy: Comparison between type 1 and type 2 animal models,” Metabolism—Clinical and Experimental, vol. 65, no. 10, pp. 1570–1581, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Kakkar, S. V. Mantha, J. Radhi, K. Prasad, and J. Kalra, “Antioxidant defense system in diabetic kidney: a time course study,” Life Sciences, vol. 60, no. 9, pp. 667–679, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. P. M. Garcia-Garcia, M. A. Getino-Melian, V. Dominguez-Pimentel, and J. F. Navarro-Gonzalez, “Inflammation in diabetic kidney disease,” World Journal of Diabetes, vol. 5, no. 4, pp. 431–443, 2014. View at Publisher · View at Google Scholar
  30. F. P. Chen, Y. Y. Kung, Y. C. Chen et al., “Frequency and pattern of Chinese herbal medicine prescriptions for chronic hepatitis in Taiwan,” Journal of Ethnopharmacology, vol. 117, no. 1, pp. 84–91, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. A. M. Blazquez-Medela, J. M. Lopez-Novoa, and C. Martinez-Salgado, “Mechanisms involved in the genesis of diabetic nephropathy,” Current Diabetes Reviews, vol. 6, no. 2, pp. 68–87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Flyvbjerg, “Inhibition and reversibility of renal changes: lessons from diabetic kidney disease,” Acta Paediatrica, vol. 95, no. 451, pp. 83–92, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Girach and L. Vignati, “Diabetic microvascular complications-can the presence of one predict the development of another?” Journal of Diabetes and Its Complications, vol. 20, no. 4, pp. 228–237, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Hovind, “Initiation, progression and remission of diabetic nephropathy,” Danish Medical Bulletin, vol. 52, no. 4, pp. 119–142, 2005. View at Google Scholar
  35. M. Y. Ali, S. Paul, E. M. Tanvir et al., “Antihyperglycemic, antidiabetic, and antioxidant effects of garcinia pedunculata in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 2979760, 15 pages, 2017. View at Publisher · View at Google Scholar
  36. Y. J. Jung, W. Park, T. Nguyen-Thanh et al., “COMP-angiopoietin-1 mitigates changes in lipid droplet size, macrophage infiltration of adipose tissue and renal inflammation in streptozotocin-induced diabetic mice,” Oncotarget, vol. 8, no. 55, pp. 94805–94818, 2017. View at Publisher · View at Google Scholar
  37. H. Niu, L. Nie, M. Liu, Y. Chi, T. Zhang, and Y. Li, “Benazepril affects integrin-linked kinase and smooth muscle α-actin expression in diabetic rat glomerulus and cultured mesangial cells,” BMC Nephrology, vol. 15, no. 1, article no. 135, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Peng, X. Chang, J. Wang, J. Zhen, X. Yang, and Z. Hu, “Protective effects of tacrolimus on podocytes in early diabetic nephropathy in rats,” Molecular Medicine Reports, vol. 15, no. 5, pp. 3172–3178, 2017. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Xue, X. Feng, C. Wang, X. Zhang, W. Sun, and K. Yu, “Benazepril hydrochloride improves diabetic nephropathy and decreases proteinuria by decreasing ANGPTL-4 expression,” BMC Nephrology, vol. 18, no. 1, article no. 307, 2017. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Huang, J. L. Haylor, Z. Hau et al., “Transglutaminase inhibition ameliorates experimental diabetic nephropathy,” Kidney International, vol. 76, no. 4, pp. 383–394, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Susztak, A. C. Raff, M. Schiffer, and E. P. Böttinger, “Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy,” Diabetes, vol. 55, no. 1, pp. 225–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. V. Gupta, S. S. Lahiri, S. Sultana, and R. Kumar, “Mechanism of action of Rhodiola imbricata Edgew during exposure to cold, hypoxia and restraint (C-H-R) stress induced hypothermia and post stress recovery in rats,” Food and Chemical Toxicology, vol. 47, no. 6, pp. 1239–1245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. J.-H. Hong, E.-Y. Hwang, H.-J. Kim, Y.-J. Jeong, and I. S. Lee, “Artemisia capillaris inhibits lipid accumulation in 3T3-L1 adipocytes and obesity in C57BL/6J mice fed a high fat diet,” Journal of Medicinal Food, vol. 12, no. 4, pp. 736–745, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. J. H. Hong and I. S. Lee, “Effects of Artemisia capillaris ethyl acetate fraction on oxidative stress and antioxidant enzyme in high-fat diet induced obese mice,” Chemico-Biological Interactions, vol. 179, no. 2-3, pp. 88–93, 2009. View at Publisher · View at Google Scholar · View at Scopus